Low Dose Calcium to Prevent Preeclampsia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1040 participants.

Also called NCT02338687

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,040 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02338687
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02338687. Randomized; no masking; primary purpose prevention. Start 2014-10 (registry gives no type); primary completion 2018-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose Calcium to Prevent Preeclampsia
Acronym
AMCAL
Condition
Pre-Eclampsia
Condition
Hypertension, Pregnancy-Induced
Condition
Dietary Calcium Deficiency
Intervention (Dietary supplement)
calcium
Intervention (Behavioral)
Educational sessions
Lead sponsor
Federal University of São Paulo (class: other)
Collaborator
PPSUS (Programa Pesquisa para o SUS: gestão compartilhada em saúde) (class: not stated)
Collaborator
FAPEAM (Fundação de Amparo a Pesquisa do Estado do Amazonas) (class: not stated)
Collaborator
Universidade Federal do Amazonas (class: other)

Record details

Record id
cardio:ct-nct02338687
Content hash
ecdfbdc373c9c51be0072baf14a0667063197e5a67cb665d178aeb1ee80ceefd